Search terms
Results 21 - 30 of 37 - ordered by :
Pages: 1 2 3 4

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 21/03/2017 Item size : 490669 bytes

Within 6-month follow-up, the time to AF relapse increased on dronedarone 800mg, with a median of 60 days vs 5.3 days in the placebo group (relative risk reduction 55% [95% CI, 28 to 72%] ...

European Heart Journal, Touboul, Paul, Brugada, Josep, Capucci, Alessandro, Crijns, Harry J.G.M., Edvardsson, Nils, Hohnloser, Stefan H.

Date : 01/08/2003 Item size : 170622 bytes

Methods and results Matched cohort study of 112 patients receiving intracoronary administration of autologous BMC and 224 heart failure patients, matched for age, gender, and left ventricular ...

European Heart Journal, Leistner, David M., Schmitt, Jörn, Palm, Sylvia, Klotsche, Jens, Estel, Stephanie, Fink, Agnes, Israel, Carsten W., Assmus, Birgit, Duray, Gabor Z., Dimmeler, Stefanie, ...

Date : 01/02/2011

Vitamin K antagonists such as warfarin are highly effective for the prevention of stroke and systemic embolism in patients with AF,1 but their use is hampered by multiple food and drug interactions, ...

European Heart Journal, Hohnloser, Stefan H., Eikelboom, John W.

Date : 01/08/2012 Item size : 155349 bytes

Citation A. John Camm, Gregory Y.H. Lip, Raffaele De Caterina, Irene Savelieva, Dan Atar, Stefan H. Hohnloser, Gerhard Hindricks, Paulus Kirchhof; 2012 focused update of the ESC Guidelines for the ...

European Heart Journal, John Camm, A., Lip, Gregory Y.H., De Caterina, Raffaele, Savelieva, Irene, Atar, Dan, Hohnloser, Stefan H., Hindricks, Gerhard, Kirchhof, Paulus

Date : 07/03/2013 Item size : 95158 bytes

[...]it has been shown that the risk of bleeding associated with warfarin therapy is particularly high in patients with CKD.7 Hence, there is a formidable clinical dilemma in AF patients who are ...

European Heart Journal, Hohnloser, Stefan H., Connolly, Stuart J.

Date : 01/10/2011 Item size : 149538 bytes

In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. Methods and results We ...

European Heart Journal, Hohnloser, Stefan H., Crijns, Harry J.G.M., van Eickels, Martin, Gaudin, Christophe, Page, Richard L., Torp-Pedersen, Christian, Connolly, Stuart J.

Date : 01/07/2010

Atrial fibrillation, European Society of Cardiology, Guidelines, Anticoagulation, Novel oral anticoagulants, Left atrial appendage occlusion, Rate control, Cardioversion, Rhythm control, ...

European Heart Journal, Camm, A. John, Lip, Gregory Y.H., De Caterina, Raffaele, Savelieva, Irene, Atar, Dan, Hohnloser, Stefan H., Hindricks, Gerhard, Kirchhof, Paulus, Bax, Jeroen J., Baumgartner, ...

Date : 01/11/2012 Item size : 1026967 bytes

[...]there are persuasive data indicating that AF complicating AMI not only increases the risk for ischaemic stroke during hospitalization but also during follow-up. Introduction Atrial fibrillation ...

European Heart Journal, Schmitt, Joern, Duray, Gabor, Gersh, Bernard J., Hohnloser, Stefan H.

Date : 01/05/2009 Item size : 331567 bytes

Beneficial effects of ACE-inhibitors on mortality and morbidity in CHF patients were demonstrated in early clinical trials.2,3 ACE-inhibition also diminishes ventricular arrhythmias after myocardial ...

European Heart Journal, Ehrlich, Joachim R., Hohnloser, Stefan H., Nattel, Stanley

Date : 01/03/2006 Item size : 240424 bytes